Anavex Life Sciences Corp. (NASDAQ:AVXL) currently has 185 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 30 Sep, 2025 | 7,188,269 | 186,507 | 2.66% | $63,975,601.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 5,104,510 | -2,357 | -0.05% | $45,430,140.00 |
| STATE STREET CORP | 30 Sep, 2025 | 3,287,118 | 338,310 | 11.47% | $29,255,350.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 2,027,327 | 7,532 | 0.37% | $18,045,452.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 1,036,954 | 63,685 | 6.54% | $9,228,891.00 |
| NWAM LLC | 30 Sep, 2025 | 874,283 | -150,196 | -14.66% | $8,174,550.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 773,012 | -4,153 | -0.53% | $6,879,808.00 |
| TWO SIGMA ADVISERS, LP | 30 Sep, 2025 | 758,500 | -64,900 | -7.88% | $6,750,650.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 30 Sep, 2025 | 717,378 | 7,762 | 1.09% | $6,384,664.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30 Sep, 2025 | 603,818 | -2,849 | -0.47% | $5,373,980.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 560,148 | -67,059 | -10.69% | $4,985,325.00 |
| LPL Financial LLC | 30 Sep, 2025 | 534,319 | -24,023 | -4.30% | $4,755,439.00 |
| UBS Group AG | 30 Sep, 2025 | 491,977 | 17,823 | 3.76% | $4,378,595.00 |
| Private Advisor Group, LLC | 30 Sep, 2025 | 455,125 | 55,900 | 14.00% | $4,050,613.00 |
| Summit Financial, LLC | 30 Sep, 2025 | 444,271 | 221,293 | 99.24% | $3,954,012.00 |
| Pier Capital, LLC | 30 Sep, 2025 | 415,906 | -8,242 | -1.94% | $3,701,563.00 |
| NATIONAL BANK OF CANADA /FI/ | 30 Sep, 2025 | 393,171 | 107,886 | 37.82% | $3,499,212.00 |
| FRANKLIN RESOURCES INC | 30 Sep, 2025 | 375,224 | 302,444 | 415.56% | $11,036,454.00 |
| JANE STREET GROUP, LLC | 30 Sep, 2025 | 308,017 | 217,736 | 241.18% | $2,741,352.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 303,389 | 9,609 | 3.27% | $2,700,163.00 |